95% of new drug candidates fail cancer clinical trials, costing billions to the pharmaceutical industry and delaying new treatments for patients.

Robust predictive human cell bioassays support faster development of preclinical trials thereby saving time and money.

We offer: R&D, drug testing, medical device co-development and testing, bioassay co-conception and open lab. We provide fully functioning 3D tissue models and specific cell models from patients which improves efficacy given their proximity to human physiology.

For: Pharmaceutical industry (cancer research, regenerative medicine, medical devices), public and private research institutions, contract research organisations.

Key product innovations:

• • World’s first mini liver as part of a NASA research programme
• • World’s first nervous tissue model
• • Stem cell applications
• • 3D microtumours

We offer: In house tests, off the shelf models, co-development/innovation. Open lab using complex skin models from any age range and typology. Skin biopsies and in-house research.

For: Cosmetic and dermatology industries

Key product innovations:

• • Ex vivo baby skin models
• • In vitro hair models
• • Sebaceous gland models
• • Pigmentation models
• • Scar and stretch marks models
• • Sensitive skin models

We offer: Human biological sample procurement & cell harvesting. Over 50 000 tissue samples in stock or on demand from bio-sourcing via a network of 200 healthcare partners worldwide

Specifically this includes:

• • Human skin cells (dermal, epidermal, melanocytes, sebocytes ...)
• • Oral and facial cells and tissues
• • Subcutaneous tissues and organs
• • Blood and bone marrow
• • Cancer and associated cells
• • Pathological tissues
• • Cell purification and characterisation (CD34, 56, T, B)

Key product innovations:

• • 3D printed tissue models
• • Animal product free human cell models